Effects, Tolerance, and Response to COVID-19 Vaccines in Hispanic Puerto Rican Patients with Multiple Sclerosis
Background: At the start of the SARS-CoV-2 (COVID-19) pandemic there was uncertainty among Multiple Sclerosis (MS) patients about starting...
Physical Activity Vital Sign in Multiple Sclerosis
Background: Exercise is Medicine is a global health initiative launched by the American College of Sports Medicine and the American Medical...
Coping Moderates the Association between Symptoms and Functional and Affective Outcomes in the Daily Lives of Individuals with Multiple Sclerosis
Background: Pain and fatigue are highly prevalent in multiple sclerosis (MS) and are associated with adverse outcomes spanning the...
Improving Communication about Multiple Sclerosis: The MS-Support Decision Aid
Background: Good communication between patients and their health care provider (HCP) is essential for shared decision making (SDM). We...
Differences in Expected Number of Clinical Management Events before and during Treatment with Sphingosine-1-Phosphate Receptor Modulators for Multiple Sclerosis
Background: Sphingosine-1-phosphate receptor modulators (S1Ps), a class of oral disease-modifying therapies (DMTs) for multiple sclerosis...
Adherence to Oral Disease Modifying Therapies in Clinical Practice and Patient-Centered Outcomes
Background: There are more than 20 disease modifying therapies (DMTs) approved for treatment of Multiple Sclerosis. Previous studies in the...
The Relationship between Illness Intrusiveness and Walking in Persons with Multiple Sclerosis
Background: Walking impairment is one of the hallmark symptoms of persons with multiple sclerosis (PwMS) and affects activities of daily...
Perceived Health Related Quality of Life and Healthcare Resource Utilization in Persons with Multiple Sclerosis with and without Vascular Comorbidity
Background: Vascular comorbidities are prevalent in the multiple sclerosis (MS) population and can contribute to adverse health outcomes in...